Lymphoma /

Martin Hutchings, MD, PhD Rigshospitalet, Copenhagen Denmark 5Live #ASCO20

6:23

Key Insights on Epcoritamab (GEN3013; DuoBody-CD3×CD20) to induce complete response in patients with relapsed/refractory B-cell non-Hodgkin lymphoma (B-NHL): Complete dose escalation data and efficacy results from a phase I/II trial.

Lymphoma

Lymphoma Similar Videos

Similar Videos

ABOUT

Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.

The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.

CONNECT

support@bioascend.com

(888) 476-9129

980 North Michigan Avenue, Suite 1400, Chicago, IL 60611

Terms and Conditions | Privacy Policy

Martin Hutchings, MD, PhD Rigshospitalet, Copenhagen Denmark 5Live #ASCO20

Lymphoma Similar Videos

IUCLS 2023 Saturday Afternoon General Session_Sonali Smith, MD, FASCO_Andrew Evens, DO, MBA, MSc_Timothy Fenske, MD, MS

Virtual Challenging Case Clinic: B-cell Lymphomas - Chronic Lymphocytic Leukemia_Jennifer Brown, MD, PhD

IUCLS 2023 Friday General Session_Sonali Smith, MD, FASCO_Andrew Evens, DO, MBA, MSc_Timothy Fenske, MD, MS

Martin Hutchings, MD, PhD Rigshospitalet, Copenhagen Denmark 5Live #ASCO20

Lymphoma Similar Videos

IUCLS 2023 Saturday Afternoon General Session_Sonali Smith, MD, FASCO_Andrew Evens, DO, MBA, MSc_Timothy Fenske, MD, MS

Virtual Challenging Case Clinic: B-cell Lymphomas - Chronic Lymphocytic Leukemia_Jennifer Brown, MD, PhD

IUCLS 2023 Friday General Session_Sonali Smith, MD, FASCO_Andrew Evens, DO, MBA, MSc_Timothy Fenske, MD, MS

Share this video

Embed